Novo Nordisk Statistics
Novo Nordisk (0TDD) Stock Statistics & Valuation Metrics
Total Valuation
Novo Nordisk has a market cap or net worth of $185.94B. The enterprise value is $181.06B.
- Market Cap
- $185.94B
- Enterprise Value
- $181.06B
Share Statistics
Novo Nordisk has 3,390,128,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 3,390,128,000
- Owned by Insiders
- ―
- Owned by Institutions
- 6.22%
Financial Efficiency
Novo Nordisk’s return on equity (ROE) is 0.53 and return on invested capital (ROIC) is 29.53%.
- Return on Equity (ROE)
- 0.53
- Return on Assets (ROA)
- 0.19
- Return on Invested Capital (ROIC)
- 29.53%
- Return on Capital Employed (ROCE)
- 0.39
- Revenue Per Employee
- 4.49M
- Profits Per Employee
- 1.49M
- Employee Count
- 68,794
- Asset Turnover
- 0.57
- Inventory Turnover
- 1.18
Valuation Ratios
The current PE Ratio of Novo Nordisk is 11.18. Novo Nordisk’s PEG ratio is 1.20.
- PE Ratio
- 11.18
- PS Ratio
- 3.77
- PB Ratio
- 5.77
- Price to FCF
- 27.04
- Price to Operating Cash Flow
- 9.79
- PEG Ratio
- 1.20
Income Statement
In the last 12 months, Novo Nordisk had revenue of 309.06B and earned 102.43B in profits. Earnings per share was 23.06.
- Revenue
- 309.06B
- Gross Profit
- 250.28B
- Operating Income
- 127.66B
- Pretax Income
- 130.54B
- Net Income
- 102.43B
- EBITDA
- 156.73B
- Earnings Per Share (EPS)
- 23.06
Cash Flow
In the last 12 months, operating cash flow was 128.15B and capital expenditures -81.82B, giving a free cash flow of 46.32B billion.
- Operating Cash Flow
- 128.15B
- Free Cash Flow
- 46.32B
- Free Cash Flow per Share
- 10.56
Dividends & Yields
Novo Nordisk pays an annual dividend of ―, resulting in a dividend yield of 4.42%
- Dividend Per Share
- ―
- Dividend Yield
- 4.42%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 3.70%
- Earnings Yield
- 9.01%
Stock Price Statistics
- Beta
- 0.86
- 52-Week Price Change
- -15.09%
- 50-Day Moving Average
- 40.06
- 200-Day Moving Average
- 42.59
- Relative Strength Index (RSI)
- 55.73
- Average Volume (3m)
- 113.48K
Important Dates
Novo Nordisk upcoming earnings date is Feb 03, 2027, Before Open (Not Confirmed).
- Last Earnings Date
- Nov 04, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Novo Nordisk as a current ratio of 0.80, with Debt / Equity ratio of 67.49%
- Current Ratio
- 0.80
- Quick Ratio
- 0.57
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- 0.67
- Interest Coverage Ratio
- 30.34
Taxes
In the past 12 months, Novo Nordisk has paid 28.11B in taxes.
- Income Tax
- 28.11B
- Effective Tax Rate
- 0.22
Enterprise Valuation
Novo Nordisk EV to EBITDA ratio is 7.65, with an EV/FCF ratio of 28.98.
- EV to Sales
- 4.04
- EV to EBITDA
- 7.65
- EV to Free Cash Flow
- 28.98
- EV to Operating Cash Flow
- 10.50
Balance Sheet
Novo Nordisk has $49.18B in cash and marketable securities with $134.48B in debt, giving a net cash position of -$85.30B billion.
- Cash & Marketable Securities
- $49.18B
- Total Debt
- $134.48B
- Net Cash
- -$85.30B
- Net Cash Per Share
- -$25.16
- Tangible Book Value Per Share
- $24.07
Margins
Gross margin is 80.79%, with operating margin of 42.39%, and net profit margin of 33.92%.
- Gross Margin
- 80.79%
- Operating Margin
- 42.39%
- Pretax Margin
- 43.36%
- Net Profit Margin
- 33.92%
- EBITDA Margin
- 52.81%
- EBIT Margin
- 42.69%
Analyst Forecast
The average price target for Novo Nordisk is $43.04, which is 11.43% higher than the current price. The consensus rating is Neutral
- Price Target
- $43.04
- Price Target Upside
- 4.79% Upside
- Analyst Consensus
- Neutral
- Analyst Count
- 5
- Revenue Growth Forecast
- 11.16%
- EPS Growth Forecast
- 15.62%
Scores
- Smart Score
- 5
- AI Score
- ―

